Skip to main content
. 2022 Jan 30;14(3):725. doi: 10.3390/cancers14030725

Table 4.

Metabolic pathways significantly (p < 0.05) upregulated or downregulated in CRC across multiple studies, as depicted in Figure 4, along with metabolites significantly up or downregulated in each pathway. Analysis was performed by using MetaboAnalyst version 5.0 (https://www.metaboanalyst.ca/home.xhtml), developed by the Xia lab, Alberta, Canada, accessed on 8 August 2021.

Pathway Metabolites Implicated p Value Regulation
Aminoacyl-tRNA biosynthesis 7 5.07 × 10−8 Upregulated
Valine, leucine, and isoleucine biosynthesis 2 0.00205 Upregulated
Butanoate Metabolism 2 0.00743 Upregulated
Histidine Metabolism 2 0.00845 Upregulated
Glycolysis or Gluconeogenesis 2 0.0217 Upregulated
Alanine, Aspartate, and glutamine metabolism 2 0.025 Upregulated
Glutathione Metabolism 2 0.025 Upregulated
Porphyrin metabolism 2 0.0285 Upregulated
Glyoxylate and dicarboxylate metabolism 2 0.0322 Upregulated
Biosynthesis of unsaturated fatty acids 2 0.04 Upregulated
Arginine and proline metabolism 2 0.0442 Upregulated
Linoleic acid metabolism 1 0.0444 Upregulated
Valine, leucine, and isoleucine degradation 2 0.0485 Upregulated
Aminoacyl-tRNA biosynthesis 9 2.46 × 10−121 Downregulated
Arginine biosynthesis 4 0.00000198 Downregulated
Alanine, aspartate, and glutamate metabolism 4 0.0000382 Downregulated
Phenylalanine, tyrosine, and tryptophan biosynthesis 2 0.000327 Downregulated
Phenylalanine metabolism 2 0.00239 Downregulated
Pantothenate and CoA biosynthesis 2 0.00873 Downregulated
D-Glutamine and D-glutamate metabolism 1 0.0456 Downregulated
Nitrogen metabolism 1 0.0456 Downregulated